These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 86621)

  • 1. [Preoperative application of NK 631 for carcinoma of oral cavity (author's transl)].
    Yamamoto E; Sunakawa H; Kohama GI
    Jpn J Antibiot; 1979 Feb; 32(2):253-8. PubMed ID: 86621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effects of NK 631 in malignant tumors of the oral cavity (author's transl)].
    Kawahira K; Dohhara Y; Sugihara K; Yamada K; Fujinami Y; Saku T; Yamashita S
    Jpn J Antibiot; 1979 Jan; 32(1):138-48. PubMed ID: 84884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with pepleomycin (NK 631) (author's transl)].
    Hashimoto K; Shioda S; Amagasa T; Shimizu M; Sato O; Ito H; Fujibayashi T; Soda T
    Jpn J Antibiot; 1979 Mar; 32(3):451-62. PubMed ID: 86627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the clinical effect of NK 631 for oral-cavity cancers (author's transl)].
    Ohashi Y; Abe M; Saito K; Mizutani H; Onishi S; Ueda N
    Jpn J Antibiot; 1979 Feb; 32(2):259-64. PubMed ID: 86622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary effect of NK 631 against head-and-neck cancers (author's transl)].
    Takata K; Honda T
    Jpn J Antibiot; 1979 Jan; 32(1):106-14. PubMed ID: 84880
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of NK 631, a new bleomycin derivative, in treatment of oral cancer (author's transl)].
    Kajiyama M; Dohjyo M; Ohno A; Nagasaka K; Yamaguma M; Okabe T; Terasaka S
    Jpn J Antibiot; 1979 Jan; 32(1):129-37. PubMed ID: 84883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of NK 631 in the treatment of cancer of the tongue and the floor of the mouth (author's transl)].
    Hayashida K; Watanabe H; Ito M; Nakashima T; Toriya Y; Hiroto I; Jingu K; Hayabuchi N
    Jpn J Antibiot; 1979 Apr; 32(4):509-15. PubMed ID: 88531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with pepleomycin (NK 631) (author's transl)].
    Kusakari J; Sato Y; Saijo S; Tomioka S; Kawamoto K
    Jpn J Antibiot; 1978 Nov; 31(11):659-63. PubMed ID: 83402
    [No Abstract]   [Full Text] [Related]  

  • 9. [The position of bleomycin in the treatment of malignant tumors in oral surgery - a critical analysis after 7 years of application (author's transl)].
    Schubert J; Wagner U
    Zahn Mund Kieferheilkd Zentralbl; 1981; 69(4):227-32. PubMed ID: 6170190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of NK 631 to head-and-neck cancers (author's transl)].
    Ogawa Y; Omata T; Imaizumi H; Shiga H; Ouchi J
    Jpn J Antibiot; 1979 Jan; 32(1):115-20. PubMed ID: 84881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with NK 631 in malignant tumors of skin (author's transl)].
    Nobe O; Kubo H; Yoshii K; Tashiro M
    Jpn J Antibiot; 1979 Mar; 32(3):463-9. PubMed ID: 86628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy for advanced oral squamous cell carcinoma with radiation and bleomycin. I. Primary regression and early mucosal reaction (author's transl)].
    Takeda M; Horiuchi J; Okuyama T; Matsubara S; Shibuya H
    Newsl Int Coll Dent India Sect; 1980 Jan; 40(1):36-42. PubMed ID: 6154281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of oral and maxillofacial squamous cell carcinomas by zhenguangmycin---with discussion on the similarities and differences between zhenguangmycin and bleomycin (author's transl)].
    Zhonghua Kou Qiang Ke Za Zhi; 1979 Jun; 14(2):77-9. PubMed ID: 95503
    [No Abstract]   [Full Text] [Related]  

  • 14. [An autopsy case of oral cancer healed by single treatment with bleomycin, with a case report of double cancer of squamous cell carcinoma and adenocarcinoma (author's transl)].
    Watanabe I; Yamazaki Y; Satoh M; Yamane G; Saito T
    Shikwa Gakuho; 1975 Nov; 75(11):1640-5. PubMed ID: 75571
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intraarterial bleomycin therapy on squamous cell carcinomas of the oral cavity. Clinico-pathological investigations (author's transl)].
    Höltje WJ; Burkhardt A; Gebbers JO; Maerker R
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Dec; 88(1):69-90. PubMed ID: 64041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined chemotherapy in the treatment of epidermoid carcinoma of the orofacial region (author's transl)].
    Danko J; Satko I
    Bratisl Lek Listy; 1979 Apr; 71(4):487-92. PubMed ID: 87249
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with NK 631 (pepleomycin) for malignant tumors of skin (author's transl)].
    Seki T; Shimada S; Ohara K
    Jpn J Antibiot; 1979 Feb; 32(2):278-81. PubMed ID: 86624
    [No Abstract]   [Full Text] [Related]  

  • 18. [Technique and clinical assessment of the intra-arterial chemotherapy of squamous cell carcinoma (author's transl)].
    Günther R; Müller W
    Arch Geschwulstforsch; 1982; 52(2):113-6. PubMed ID: 6179496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of NK 631, a new derivative of bleomycin (author's transl)].
    Asahi M
    Jpn J Antibiot; 1979 Jul; 32(7):744-50. PubMed ID: 90742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy in the treatment of intra-oral squamous cell carcinoma.
    Chander S; Ghosh D
    Indian J Cancer; 1987 Jun; 24(2):67-72. PubMed ID: 2447013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.